Neostigmine Methylsulfate - NDC Database (Page 3)
72 records found
Page:
63323-383 Sep 01, 2000
Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC
Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC
63323-413 Jan 08, 2015
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
63323-415 Jan 08, 2015
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
65145-111 Apr 30, 2021
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Caplin Steriles Limited
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Caplin Steriles Limited
65145-112 Apr 30, 2021
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Caplin Steriles Limited
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Caplin Steriles Limited
65219-811 Jan 08, 2015
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
68083-383 Oct 21, 2019
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Gland Pharma Limited
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Gland Pharma Limited
68083-384 Oct 21, 2019
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Gland Pharma Limited
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Gland Pharma Limited
70069-805 Jan 10, 2022
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Somerset Therapeutics, LLC
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Somerset Therapeutics, LLC
70069-806 Jan 10, 2022
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Somerset Therapeutics, LLC
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Somerset Therapeutics, LLC
70121-1478 Jun 20, 2018
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Amneal Biosciences LLC
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Amneal Biosciences LLC
70121-1479 Jun 20, 2018
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Amneal Biosciences LLC
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Amneal Biosciences LLC
70594-069 Jan 10, 2021
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Xellia Pharmaceuticals USA LLC
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Xellia Pharmaceuticals USA LLC
70594-072 Jan 10, 2021
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Xellia Pharmaceuticals USA LLC
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Xellia Pharmaceuticals USA LLC
71288-500 Apr 05, 2021
Neostigmine Methylsulfate .51 mg/ml Intravenous Injection by Meitheal Pharmaceuticals Inc.
Neostigmine Methylsulfate .51 mg/ml Intravenous Injection by Meitheal Pharmaceuticals Inc.
71288-501 Apr 05, 2021
Neostigmine Methylsulfate 1.02 mg/ml Intravenous Injection by Meitheal Pharmaceuticals Inc.
Neostigmine Methylsulfate 1.02 mg/ml Intravenous Injection by Meitheal Pharmaceuticals Inc.
71839-105 May 13, 2019
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Be Pharmaceuticals Inc.
Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Be Pharmaceuticals Inc.
71839-106 May 13, 2019
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Be Pharmaceuticals Inc.
Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Be Pharmaceuticals Inc.
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.